April 2024
1. MAYER M
   Letter by Mayer Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
   Circulation. 2024;149:e1109-e1110.
   

   >> Share

   
   
2. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
   Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants".
   Circulation. 2024;149:e1111-e1112.
   

   >> Share

   
   
3. CHUGH SS
   Prevention of Sudden Cardiac Death: Beyond Automated External Defibrillators and Implantable Cardioverter Defibrillators.
   Circulation. 2024;149:1059-1061.
   

   >> Share

   
   March 2024
4. PATEL SM, Ruff CT
   Subclinical Atrial Fibrillation and Anticoagulation: Weighing the Absolute Risks and Benefits.
   Circulation. 2024;149:989-992.
   

   >> Share

   
   
5. REIFFEL JA
   Atrial Fibrillation: Why Are We Hiding Reality?
   Circulation. 2024;149:979-980.
   

   >> Share

   
   
6. LEE CH, Scheinman MM
   Wide Complex Tachycardia: Mind Your Medicine!
   Circulation. 2024;149:963-966.
   

   >> Share

   
   
7. KOWEY PR, Naccarelli GV
   Antiarrhythmic Drug Therapy: Where Do We Go From Here?
   Circulation. 2024;149:801-803.
   

   >> Share

   
   
8. KLEIMAN NS, Goel SS
   The Shape of Things to Come? Is a Trial of Combined Interventional Procedures Necessary in Today's World?
   Circulation. 2024;149:744-746.
   

   >> Share

   
   
9. BATRA AS, Silka MJ, Borquez A, Cuneo B, et al
   Pharmacological Management of Cardiac Arrhythmias in the Fetal and Neonatal Periods: A Scientific Statement From the American Heart Association: Endorsed by the Pediatric & Congenital Electrophysiology Society (PACES).
   Circulation. 2024;149:e937-e952.
   

   >> Share

   
   February 2024
10. 
    Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e936.
    

    >> Share

    
    
11. HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al
    mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
    Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130.
    

    >> Share

    
    
12. LIN AE, Bapat AC, Xiao L, Niroula A, et al
    Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation.
    Circulation. 2024 Feb 15. doi: 10.1161/CIRCULATIONAHA.123.065597.
    

    >> Share

    
    
13. SANCHEZ RH, Hamdan H, Torrealba J, Grodin JL, et al
    Giants Hiding in Small Places: A Case of New Onset Heart Failure, Atrioventricular Block, and Ventricular Arrhythmias.
    Circulation. 2024;149:475-480.
    

    >> Share

    
    
14. GALEA R, Meneveau N, De Marco F, Aminian A, et al
    One-Year Outcomes After Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: A Prespecified Analysis of the SWISS-APERO Randomized Clinical Trial.
    Circulation. 2024;149:484-486.
    

    >> Share

    
    January 2024
15. LEE SY, Lee BK
    Palpitations and Recurrent Syncope in a Young Woman.
    Circulation. 2024;149:402-405.
    

    >> Share

    
    
16. HERWEG B, Sharma PS, Cano O, Ponnusamy SS, et al
    Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Circulation. 2024;149:379-390.
    

    >> Share

    
    
17. PATEL SM, Braunwald E, Steffel J, Boriani G, et al
    Efficacy and Safety of Non-Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of Four Randomized Clinical Trials of 58 464 Patients With Atrial Fibr
    Circulation. 2024 Jan 24. doi: 10.1161/CIRCULATIONAHA.123.066279.
    

    >> Share

    
    
18. WALLENTIN L, Giugliano RP
    Switching to Direct Anticoagulation or Continued Vitamin-K Antagonists in Frail Patients With Atrial Fibrillation in Whom Vitamin-K Antagonists Are Tolerated?
    Circulation. 2024;149:290-292.
    

    >> Share

    
    
19. BROMAN MT, Nadadur RD, Perez-Cervantes C, Burnicka-Turek O, et al
    A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.
    Circulation. 2024 Jan 8. doi: 10.1161/CIRCULATIONAHA.123.066804.
    

    >> Share

    
    
20. 
    Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2024;149:e167.
    

    >> Share

    
    December 2023
21. OSTERGAARD L, Olesen JB, Petersen JK, Nielsen LS, et al
    Arterial Thromboembolism in Patients With Atrial Fibrillation and CHA(2)DS(2)-VASc 1: A Nationwide Study.
    Circulation. 2023 Dec 28. doi: 10.1161/CIRCULATIONAHA.123.066477.
    

    >> Share

    
    
22. BERGEMAN AT, Lieve KVV, Kallas D, Bos JM, et al
    Flecainide Is Associated With a Lower Incidence of Arrhythmic Events in a Large Cohort of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2023;148:2029-2037.
    

    >> Share

    
    
23. VAN DUIJVENBODEN S, Ramirez J, Orini M, Aung N, et al
    Prognostic Significance of Different Ventricular Ectopic Burdens During Submaximal Exercise in Asymptomatic UK Biobank Subjects.
    Circulation. 2023;148:1932-1944.
    

    >> Share

    
    
24. KATAOKA N, Imamura T, Kinugawa K
    Letter by Kataoka et al Regarding Article, "Long-Term Outcomes of Brugada Substrate Ablation: A Report From BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry)".
    Circulation. 2023;148:1914.
    

    >> Share

    
    November 2023
25. JOGLAR JA, Chung MK, Armbruster AL, Benjamin EJ, et al
    2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    Circulation. 2023 Nov 30. doi: 10.1161/CIR.0000000000001193.
    

    >> Share

    
    
26. KHIDHIR A, Curtis AB
    Perspective on ACC/AHA/ACCP/HRS Guidelines for the Management of Atrial Fibrillation.
    Circulation. 2023 Nov 30. doi: 10.1161/CIRCULATIONAHA.123.066919.
    

    >> Share

    
    
27. ROWIN EJ, Link MS, Maron MS, Maron BJ, et al
    Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2023;148:1797-1811.
    

    >> Share

    
    
28. HIGUCHI S, Voskoboinik A, Il Im S, Lee A, et al
    Frequent Premature Atrial Contractions Lead to Adverse Atrial Remodeling and Atrial Fibrillation in a Swine Model.
    Circulation. 2023 Nov 23. doi: 10.1161/CIRCULATIONAHA.123.065874.
    

    >> Share

    
    
29. GONZALEZ-TORRECILLA E, Luna Lopez R, Avila Alonso P
    Atrioventricular Block: Does This Patient Require a Pacemaker?
    Circulation. 2023;148:1725-1727.
    

    >> Share

    
    
30. SEO K, Yamamoto Y, Kirillova A, Kawana M, et al
    Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
    Circulation. 2023;148:1691-1704.
    

    >> Share

    
    
31. QI M, Ma S, Liu J, Liu X, et al
    In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice.
    Circulation. 2023 Nov 15. doi: 10.1161/CIRCULATIONAHA.123.065624.
    

    >> Share

    
    
32. WILDE AAM, Saenen J
    Risk Stratification in Brugada Syndrome: How Low Can We Go?
    Circulation. 2023;148:1556-1558.
    

    >> Share

    
    
33. BELBACHIR N, Wu Y, Shen M, Zhang SL, et al
    Studying Long QT Syndrome Caused by NAA10 Genetic Variants Using Patient-Derived Induced Pluripotent Stem Cells.
    Circulation. 2023;148:1598-1601.
    

    >> Share

    
    
34. KIM MC, Lim Y, Lee SH, Shin Y, et al
    Early Left Ventricular Unloading or Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: The EARLY-UNLOAD Randomized Clinical Trial.
    Circulation. 2023;148:1570-1581.
    

    >> Share

    
    
35. GAITA F, Cerrato N, Giustetto C, Martino A, et al
    Asymptomatic Patients With Brugada ECG Pattern: Long-Term Prognosis From a Large Prospective Study.
    Circulation. 2023;148:1543-1555.
    

    >> Share

    
    
36. HOSOKAWA K, Watanabe H, Taniguchi Y, Ikeda N, et al
    A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI Trial.
    Circulation. 2023 Nov 13. doi: 10.1161/CIRCULATIONAHA.123.067528.
    

    >> Share

    
    
37. MCINTYRE WF, Benz AP, Becher N, Healey JS, et al
    Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.
    Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512.
    

    >> Share

    
    
38. POKORNEY SD, Granger CB
    The Need for Randomized Trials to Define the Optimal Dose of Anticoagulants for Atrial Fibrillation in Chronic Kidney Disease.
    Circulation. 2023;148:1455-1458.
    

    >> Share

    
    October 2023
39. STEVENSON WG, Tandri H, Roden DM
    The Shape of Ventricular Tachycardia.
    Circulation. 2023;148:1368-1370.
    

    >> Share

    
    
40. NISHIMURA T, Shatz N, Weiss JP, Zawaneh M, et al
    Identification of Human Ventricular Tachycardia Demarcated by Fixed Lines of Conduction Block in a 3-Dimensional Hyperboloid Circuit.
    Circulation. 2023;148:1354-1367.
    

    >> Share

    
    
41. KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al
    Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients with Atrial Fibrillation.
    Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312.
    

    >> Share

    
    
42. O'HARA PE, Venkatesh V, Lehrenbaum H
    A Unique Case of Right Axis Deviation.
    Circulation. 2023;148:1261-1262.
    

    >> Share

    
    
43. KRISAI P, Kuhne M, Sticherling C
    Letter by Krisai et al Regarding Article, "Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial".
    Circulation. 2023;148:1182.
    

    >> Share

    
    
44. BUTT JH, Yafasova A, Doi SN, Nielsen JC, et al
    Implantable Cardioverter Defibrillator in Patients With Nonischemic Systolic Heart Failure With and Without Cardiac Resynchronization Therapy: Extended Follow-Up Study of the DANISH Trial.
    Circulation. 2023;148:1179-1181.
    

    >> Share

    
    September 2023
45. PARKASH R, O'Meara E, Tang ASL
    The Role of Ablation-Based Rhythm Control in the Tangled Web of Atrial Fibrillation and Heart Failure.
    Circulation. 2023;148:933-935.
    

    >> Share

    
    
46. EZEKOWITZ MD, Kamareddine M
    Filling an Important Knowledge Gap: The DOAC Score.
    Circulation. 2023;148:947-949.
    

    >> Share

    
    
47. PERERA D, Morgan HP, Ryan M, Dodd M, et al
    Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.
    Circulation. 2023;148:862-871.
    

    >> Share

    
    
48. XU Y, Chang AR, Inker LA, McAdams-DeMarco M, et al
    Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease.
    Circulation. 2023 Sep 8. doi: 10.1161/CIRCULATIONAHA.123.065614.
    

    >> Share

    
    
49. PUNDI K, Marcus GM, Turakhia M
    The Epidemic and Data-Free Zone of Nonsustained Ventricular Tachycardia: An Unintended Consequence of Digital Monitoring and a Path Forward.
    Circulation. 2023;148:805-807.
    

    >> Share

    
    
50. XIAO SY, Goldschlager N, Durstenfeld MS
    Chest Pain, Bundle Branch Block, and Wide Complex Tachycardia: Is Three a Company or Crowd?
    Circulation. 2023;148:845-847.
    

    >> Share

    
    August 2023
51. JOOSTEN LPT, van Doorn S, van de Ven PM, Kohlen BTG, et al
    Safety of Switching from a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients with Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial.
    Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066485.
    

    >> Share

    
    
52. AGGARWAL R, Ruff CT, Virdone S, Perreault S, et al
    Development and Validation of the DOAC Score: A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants.
    Circulation. 2023 Aug 25. doi: 10.1161/CIRCULATIONAHA.123.064556.
    

    >> Share

    
    
53. MUSTROPH J, Baier MJ, Unsin D, Provaznik Z, et al
    Ethanol-Induced Atrial Fibrillation Results From Late I(Na) and Can Be Prevented by Ranolazine.
    Circulation. 2023;148:698-700.
    

    >> Share

    
    
54. ALGALARRONDO V, Extramiana F
    Autoimmune Atrial Fibrillation or Atrial Fibrillation-Induced Autoimmunity? A New Atrial Fibrillation Begets Atrial Fibrillation Pathway?
    Circulation. 2023;148:499-501.
    

    >> Share

    
    
55. JIAO T, Ruzieh M
    Letter by Jiao and Ruzieh Regarding Article, "Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex".
    Circulation. 2023;148:508-509.
    

    >> Share

    
    
56. RAJJOUB K, Rajjoub EA, Ramos-Jimenez J
    What Is the Mechanism of the Premature Beats?
    Circulation. 2023;148:426-429.
    

    >> Share

    
    July 2023
57. VAZQUEZ E, Vazquez-Sanchez T, Sanchez-Perales C
    Letter by Vazquez et al Regarding Article, "Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial".
    Circulation. 2023;148:378.
    

    >> Share

    
    
58. YOUNIS A, Ali S, Hsich E, Goldenberg I, et al
    Arrhythmia and Survival Outcomes Among Black Patients and White Patients With a Primary Prevention Defibrillator.
    Circulation. 2023;148:241-252.
    

    >> Share

    
    
59. AL-KHATIB SM, Thomas KL
    Advancing Equity in Sudden Cardiac Death Prevention: Beware of Making Assumptions About the Effectiveness of Primary Prevention Implantable Cardioverter-Defibrillators in Black Patients.
    Circulation. 2023;148:253-255.
    

    >> Share

    
    
60. HAISSAGUERRE M, Duchateau J, Laredo M, Lavergne T, et al
    Inducibility of Short-Coupled Purkinje Ectopy by Pharmacological Tests in Patients With Spontaneous Short-Coupled Idiopathic Ventricular Fibrillation.
    Circulation. 2023;148:70-72.
    

    >> Share

    
    
61. MAGUY A, Mahendran Y, Tardif JC, Busseuil D, et al
    Autoimmune Atrial Fibrillation.
    Circulation. 2023 Jul 4. doi: 10.1161/CIRCULATIONAHA.122.062776.
    

    >> Share

    
    June 2023
62. HOCHSTADT A, Geist M, Viskin S
    Occam's Razor: Two Arrhythmias in a Single Heart?
    Circulation. 2023;147:1779-1781.
    

    >> Share

    
    
63. COULT J, Yang BY, Kwok H, Kutz JN, et al
    Prediction of Shock-Refractory Ventricular Fibrillation During Resuscitation of Out-of-Hospital Cardiac Arrest.
    Circulation. 2023 Jun 2. doi: 10.1161/CIRCULATIONAHA.122.063651.
    

    >> Share

    
    May 2023
64. DOUNDOULAKIS I, Tsioufis K, Gatzoulis KA
    Letter by Doundoulakis et al Regarding Article, "Programmed Ventricular Stimulation as Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy".
    Circulation. 2023;147:1714.
    

    >> Share

    
    
65. MILES C, Boukens BJ, Scrocco C, Wilde AAM, et al
    Subepicardial Cardiomyopathy: A Disease Underlying J-Wave Syndromes and Idiopathic Ventricular Fibrillation.
    Circulation. 2023;147:1622-1633.
    

    >> Share

    
    
66. VISKIN S, Rosso R
    Treatment of Brugada Syndrome in 2023: Know Where You Come From to Know Where You Are Going.
    Circulation. 2023;147:1579-1581.
    

    >> Share

    
    
67. NADEMANEE K, Chung FP, Sacher F, Nogami A, et al
    Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Circulation. 2023;147:1568-1578.
    

    >> Share

    
    
68. TURAGAM MK, Neuzil P, Schmidt B, Reichlin T, et al
    Safety and Effectiveness of Pulsed Field Ablation to Treat Atrial Fibrillation: One-Year Outcomes From the MANIFEST-PF Registry.
    Circulation. 2023 May 18. doi: 10.1161/CIRCULATIONAHA.123.064959.
    

    >> Share

    
    
69. RUSSO AM
    Pulsed Field Ablation: Is It Better Than Conventional Thermal Ablation for Treatment of Atrial Fibrillation?
    Circulation. 2023;147:1433-1435.
    

    >> Share

    
    
70. GUPTA AR, Deshmukh AJ, Del-Carpio Munoz F
    A Tale of Two Parallel Rhythms.
    Circulation. 2023;147:1463-1466.
    

    >> Share

    
    
71. DUAN H, Zhang CH
    A Series of Abnormal ECGs: Are They Benign or Sinister?
    Circulation. 2023;147:1407-1410.
    

    >> Share

    
    
72. WANG Y, Wang J, Shi L, Chen X, et al
    CIB2 Is a Novel Endogenous Repressor of Atrial Remodeling.
    Circulation. 2023 May 2. doi: 10.1161/CIRCULATIONAHA.122.062660.
    

    >> Share

    
    April 2023
73. 
    Correction to: Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023;147:e717.
    

    >> Share

    
    
74. XING LY, Diederichsen SZ, Hojberg S, Krieger DW, et al
    Effects of Systematic Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: a Secondary Analysis of the Randomized LOOP Study.
    Circulation. 2023 Apr 15. doi: 10.1161/CIRCULATIONAHA.123.064361.
    

    >> Share

    
    
75. HARRINGTON J, Carnicelli AP, Hua K, Wallentin L, et al
    Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Circulation. 2023 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.062752.
    

    >> Share

    
    
76. KIM JU, Bray J, Ahmad M
    Letter by Kim et al Regarding Article, "Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study".
    Circulation. 2023;147:1186-1187.
    

    >> Share

    
    March 2023
77. BAPAT A, Schloss MJ, Yamazoe M, Grune J, et al
    A Mouse Model of Atrial Fibrillation in Sepsis.
    Circulation. 2023;147:1047-1049.
    

    >> Share

    
    
78. CHYOU JY, Barkoudah E, Dukes JW, Goldstein LB, et al
    Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.
    Circulation. 2023 Mar 13. doi: 10.1161/CIR.0000000000001133.
    

    >> Share

    
    
79. HYDES TJ, Lip GYH, Lane DA
    Use of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Liver Disease.
    Circulation. 2023;147:795-797.
    

    >> Share

    
    
80. FRIEDMAN DJ, Al-Khatib SM, Dalgaard F, Fudim M, et al
    Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.
    Circulation. 2023;147:812-823.
    

    >> Share

    
    
81. VERMA A, Haines DE, Boersma LV, Sood N, et al
    Pulsed Field Ablation for the Treatment of Atrial Fibrillation: PULSED AF Pivotal Trial.
    Circulation. 2023 Mar 6. doi: 10.1161/CIRCULATIONAHA.123.063988.
    

    >> Share

    
    February 2023
82. CONWAY J, Min S, Villa C, Weintraub RG, et al
    The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
    Circulation. 2023;147:718-727.
    

    >> Share

    
    
83. ZEITLER EP, Kearing S, Coylewright M, Nair D, et al
    Comparative Effectiveness of Left Atrial Appendage Occlusion Versus Oral Anticoagulation by Sex.
    Circulation. 2023;147:586-596.
    

    >> Share

    
    
84. LAWAL OD, Aronow HD, Shobayo F, Hume AL, et al
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study.
    Circulation. 2023 Feb 10. doi: 10.1161/CIRCULATIONAHA.122.060687.
    

    >> Share

    
    January 2023
85. HIGASHIKUNI Y, Liu W, Numata G, Tanaka K, et al
    NLRP3 Inflammasome Activation Through Heart-Brain Interaction Initiates Cardiac Inflammation and Hypertrophy During Pressure Overload.
    Circulation. 2023;147:338-355.
    

    >> Share

    
    
86. HAGHIGHAT L, Goldschlager N, Oesterle A
    ECG Challenge: AV Block or Something Else?
    Circulation. 2023;147:267-270.
    

    >> Share

    
    
87. YANG Z, Zhang CH, Li X
    What Is the Truth Behind Abnormal ECG Changes?
    Circulation. 2023;147:175-177.
    

    >> Share

    
    December 2022
88. WEITZ JI, Eikelboom JW
    What Is the Future of Factor XI Inhibitors?
    Circulation. 2022;146:1899-1902.
    

    >> Share

    
    
89. SHELBAYA K, Claggett B, Dorbala P, Skali H, et al
    Stages of Valvular Heart Disease Among Older Adults in the Community: The Atherosclerosis Risk in Communities Study.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.061396.
    

    >> Share

    
    
90. BERSELL KR, Yang T, Mosley JD, Glazer AM, et al
    Transcriptional Dysregulation Underlies Both Monogenic Arrhythmia Syndrome and Common Modifiers of Cardiac Repolarization.
    Circulation. 2022 Dec 16. doi: 10.1161/CIRCULATIONAHA.122.062193.
    

    >> Share

    
    
91. MARK ESTES NA, Jain S, Saba S
    Coronary Vasospasm With Pulse Field Ablation: Primum Non Nocere.
    Circulation. 2022;146:1820-1822.
    

    >> Share

    
    
92. MARCUS GM
    Smartwatch-Detected Atrial Fibrillation: The "Value" in the Positive Predictive Value.
    Circulation. 2022;146:1733-1734.
    

    >> Share

    
    
93. BENZ AP, Eikelboom JW
    Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and End-Stage Renal Disease: Lessons Learned.
    Circulation. 2022;146:1746-1748.
    

    >> Share

    
    
94. THIAGARAJAN N, Ho WHH, Lim DYZ, Loo WTW, et al
    Yield of Cardiac Magnetic Resonance Imaging in a Preparticipation Cohort of Young Asian Males With T Wave Inversion.
    Circulation. 2022;146:1802-1804.
    

    >> Share

    
    November 2022
95. PRASAD P, Howell S, Sanghai S, Stecker E, et al
    Targeted Screening for Transthyretin Amyloid Cardiomyopathy in Patients With Atrial Fibrillation.
    Circulation. 2022;146:1730-1732.
    

    >> Share

    
    
96. VALDERRABANO M, Fuentes Rojas SC, Lador A, Patel A, et al
    Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease.
    Circulation. 2022;146:1644-1656.
    

    >> Share

    
    
97. PRYSTOWSKY EN
    Rate Versus Rhythm Control for Atrial Fibrillation: Has the Debate Been Settled?
    Circulation. 2022;146:1561-1563.
    

    >> Share

    
    
98. SCHINNER C, Xu L, Franz H, Zimmermann A, et al
    Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-alphaVbeta6/TGF-beta Signaling Cascade.
    Circulation. 2022;146:1610-1626.
    

    >> Share

    
    
99. ZHANG S, Liu S, Leach JP, Li K, et al
    Gene Therapy Knockdown of Hippo Signaling Resolves Arrhythmic Events in Pigs After Myocardial Infarction.
    Circulation. 2022;146:1558-1560.
    

    >> Share

    
    
100. BRANDES A, Stavrakis S, Freedman B, Antoniou S, et al
     Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
     Circulation. 2022;146:1461-1474.
     

     >> Share

     
     
101. HAN J, Husband G, Doppalapudi H
     Tachycardia Associated With Pacing.
     Circulation. 2022;146:1475-1477.
     

     >> Share

     
     
102. KANAOKA K, Onoue K, Terasaki S, Nakano T, et al
     Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.
     Circulation. 2022;146:1425-1433.
     

     >> Share

     
     
103. 
     Correction to: Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
     Circulation. 2022;146:e279.
     

     >> Share

     
     
104. POKORNEY SD, Chertow GM, Al-Khalidi HR, Gallup D, et al
     Apixaban for Patients with Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.121.054990.
     

     >> Share

     
     
105. REINECKE H, Engelbertz C, Bauersachs R, Breithardt G, et al
     A Randomized Controlled Trial Comparing Apixaban to the Vitamin K-antagonist Phenprocoumon in Patients on Chronic Hemodialysis: The AXADIA-AFNET 8 study.
     Circulation. 2022 Nov 6. doi: 10.1161/CIRCULATIONAHA.122.062779.
     

     >> Share

     
     October 2022
106. VISKIN S, Chorin E, Schwartz AL, Kukla P, et al
     Arrhythmogenic Effects of Cardiac Memory.
     Circulation. 2022;146:1170-1181.
     

     >> Share

     
     
107. GASPERETTI A, Carrick RT, Costa S, Compagnucci P, et al
     Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study.
     Circulation. 2022 Oct 7:101161CIRCULATIONAHA122060866.
     

     >> Share

     
     September 2022
108. PATTEN RD, Shah SP
     Addressing the Risk of Ventricular Arrhythmias and Sudden Death in Patients With Cardiac Sarcoidosis.
     Circulation. 2022;146:976-979.
     

     >> Share

     
     
109. 
     Correction to: Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Risk of Heart Failure and Atrial Fibrillation.
     Circulation. 2022;146:e186.
     

     >> Share

     
     
110. LUBITZ SA, Faranesh AZ, Selvaggi C, Atlas SJ, et al
     Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
     Circulation. 2022 Sep 23:101161CIRCULATIONAHA122060291.
     

     >> Share

     
     
111. REDDY VY, Petru J, Funasako M, Kopriva K, et al
     Coronary Arterial Spasm During Pulsed Field Ablation to Treat Atrial Fibrillation.
     Circulation. 2022 Sep 22:101161CIRCULATIONAHA122061497.
     

     >> Share

     
     
112. AL-KHATIB SM, Wojdyla DM, Granger CB, Wallentin L, et al
     Duration of Anticoagulation Interruption Before Invasive Procedures and Outcomes in Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
     Circulation. 2022;146:958-960.
     

     >> Share

     
     
113. TSAI CF, Chuang YT, Chang KW
     A Peculiar Wide Complex Tachycardia During Flecainide Treatment.
     Circulation. 2022;146:955-957.
     

     >> Share

     
     
114. YANG E, Calkins H
     Who Benefits Most From Early Rhythm Control in Newly Diagnosed Atrial Fibrillation?
     Circulation. 2022;146:848-850.
     

     >> Share

     
     
115. OLDGREN J, Asberg S, Hijazi Z, Wester P, et al
     Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study.
     Circulation. 2022 Sep 6:101161CIRCULATIONAHA122060666.
     

     >> Share

     
     August 2022
116. MEHRA R, Chung MK, Olshansky B, Dobrev D, et al
     Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association.
     Circulation. 2022;146:e119-e136.
     

     >> Share

     
     
117. ZHAO Y, Riching AS, Knight WE, Chi C, et al
     Cardiomyocyte-Specific Long Noncoding RNA Regulates Alternative Splicing of the Triadin Gene in the Heart.
     Circulation. 2022;146:699-714.
     

     >> Share

     
     
118. NORDENSWAN HK, Poyhonen P, Lehtonen J, Ekstrom K, et al
     Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
     Circulation. 2022 Aug 24:101161CIRCULATIONAHA121058120.
     

     >> Share

     
     
119. RADINOVIC A, Della Bella P
     Response by Radinovic and Della Bella to Letter Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
     Circulation. 2022;146:e71-e72.
     

     >> Share

     
     
120. BENALI K, Guenancia C, Martins RP
     Letter by Benali et al Regarding Article, "Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial".
     Circulation. 2022;146:e69-e70.
     

     >> Share

     
     
121. RILLIG A, Borof K, Breithardt G, Camm AJ, et al
     Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden.
     Circulation. 2022 Aug 15:101161CIRCULATIONAHA122060274.
     

     >> Share

     
     July 2022
122. VAN DER STUIJT W, Smeding L, Olde Nordkamp LRA, Knops RE, et al
     Response by van der Stuijt et al to Letter Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial
     Circulation. 2022;146:e10-e11.
     

     >> Share

     
     
123. MADIAS C, Madias JE
     Letter by Madias and Madias Regarding Article, "Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial".
     Circulation. 2022;146:e8-e9.
     

     >> Share

     
     
124. REDDY YNV, Borlaug BA, Gersh BJ
     Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction.
     Circulation. 2022;146:339-357.
     

     >> Share

     
     
125. ESSIEN UR, Johnson AE
     Whose Streets? Neighborhood-Level Determinants of Atrial Fibrillation Care.
     Circulation. 2022;146:172-174.
     

     >> Share

     
     
126. SHAH RA, Asatryan B, Sharaf Dabbagh G, Aung N, et al
     Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
     Circulation. 2022;146:110-124.
     

     >> Share

     
     
127. TONG D, Schiattarella GG, Jiang N, Daou D, et al
     Impaired AMP-Activated Protein Kinase Signaling in Heart Failure With Preserved Ejection Fraction-Associated Atrial Fibrillation.
     Circulation. 2022;146:73-76.
     

     >> Share

     
     June 2022
128. AVENDANO R, Lavi N, Rosenfeld LE
     Around and Around...A Wide Complex Tachycardia.
     Circulation. 2022;145:1867-1869.
     

     >> Share

     
     
129. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
     Can Early Ablation of Ventricular Tachycardia Improve Survival?
     Circulation. 2022;145:1850-1852.
     

     >> Share

     
     
130. TUNG R, Xue Y, Chen M, Jiang C, et al
     First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
     Circulation. 2022;145:1839-1849.
     

     >> Share

     
     
131. CHEW DS, Li Y, Cowper PA, Anstrom KJ, et al
     Cost-Effectiveness of Catheter Ablation Versus Antiarrhythmic Drug Therapy in Atrial Fibrillation: The CABANA Randomized Clinical Trial.
     Circulation. 2022 Jun 21:101161CIRCULATIONAHA122058575.
     

     >> Share

     
     
132. MORGAN E, Anderson J, Noheria A
     Premature Complexes and Blocked P Wave.
     Circulation. 2022;145:1803-1805.
     

     >> Share

     
     
133. ABDEL-QADIR H, Akioyamen LE, Fang J, Pang A, et al
     Association of Neighborhood-Level Material Deprivation With Atrial Fibrillation Care in a Single-Payer Health Care System: A Population-Based Cohort Study.
     Circulation. 2022 Jun 9:101161CIRCULATIONAHA122058949.
     

     >> Share

     
     
134. POKORNEY SD, Granger CB
     Evidence Builds for Catheter Ablation for Atrial Fibrillation and Heart Failure.
     Circulation. 2022;145:1705-1707.
     

     >> Share

     
     May 2022
135. MAQSOOD N, Cooper JM, Whitman IR
     Letter by Maqsood et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1054-e1055.
     

     >> Share

     
     
136. IBRAHIM OA, Belley-Cote EP, McIntyre WF
     Letter by Ibrahim et al Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1056.
     

     >> Share

     
     
137. SCHMIDT AS, Lauridsen KG, Albertsen AE, Lofgren B, et al
     Response to Letters Regarding Article, "Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation".
     Circulation. 2022;145:e1057-e1058.
     

     >> Share

     
     
138. NAUFFAL V, Morrill VN, Jurgens SJ, Choi SH, et al
     Monogenic and Polygenic Contributions to QTc Prolongation in the Population.
     Circulation. 2022;145:1524-1533.
     

     >> Share

     
     
139. VAN OPBERGEN CJM, Bagwan N, Maurya SR, Kim JC, et al
     Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2-Deficient Hearts.
     Circulation. 2022;145:1480-1496.
     

     >> Share

     
     
140. GROENEVELD SA, van der Ree MH, Mulder BA, Balt J, et al
     Prevalence of Short-Coupled Ventricular Fibrillation in a Large Cohort of Dutch Patients With Idiopathic Ventricular Fibrillation.
     Circulation. 2022;145:1437-1439.
     

     >> Share

     
     April 2022
141. NATALE A, Kar S, Holmes D
     Letter by Natale et al Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e847-e848.
     

     >> Share

     
     
142. PRICE MJ, Gibson DN, Kar S
     Letter by Price et al Regarding the Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e849.
     

     >> Share

     
     
143. DHRUVA SS, Redberg RF
     Letter by Dhruva and Redberg Regarding Article, "Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial".
     Circulation. 2022;145:e845-e846.
     

     >> Share

     
     
144. HOCHSTADT A, Rosso R, Viskin S
     Sinus Node Dysfunction With a Nice Twist.
     Circulation. 2022;145:1285-1287.
     

     >> Share

     
     
145. 
     Correction to: Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
     Circulation. 2022;145:e842.
     

     >> Share

     
     
146. FATKIN D, Cox CD, Martinac B
     Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation.
     Circulation. 2022;145:1037-1039.
     

     >> Share

     
     
147. DELLA BELLA P, Baratto F, Vergara P, Bertocchi P, et al
     Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
     Circulation. 2022 Apr 3. doi: 10.1161/CIRCULATIONAHA.122.059598.
     

     >> Share

     
     March 2022
148. EXTRAMIANA F, Steg PG
     Atrial Fibrillation Screening: The Tools Are Ready, But Should We Do It?
     Circulation. 2022;145:955-958.
     

     >> Share

     
     
149. MUGNAI G, Gambaro A, Ribichini FL
     A Tachycardia in Disguise.
     Circulation. 2022;145:1024-1028.
     

     >> Share

     
     
150. PARKASH R, Wells GA, Rouleau J, Talajic M, et al
     Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients with Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.
     Circulation. 2022 Mar 22. doi: 10.1161/CIRCULATIONAHA.121.057095.
     

     >> Share

     
     
151. WALSH R, Bezzina C, Wilde AAM
     First Steps of Population Genomic Medicine in the Arrhythmia World: Pros and Cons.
     Circulation. 2022;145:892-895.
     

     >> Share

     
     
152. GLAZER AM, Davogustto G, Shaffer CM, Vanoye CG, et al
     Arrhythmia Variant Associations and Reclassifications in the eMERGE-III Sequencing Study.
     Circulation. 2022;145:877-891.
     

     >> Share

     
     
153. ANDRADE JG, Macle L
     Atrial Fibrillation Ablation: Aiming to Improve Quantity and Quality of Life.
     Circulation. 2022;145:805-807.
     

     >> Share

     
     
154. TANG Y, Zhang Y, Yang XY
     Rare Case of Wide QRS Tachycardia After Sintilimab Treatment for Lung Cancer.
     Circulation. 2022;145:783-786.
     

     >> Share

     
     
155. KOWALEWSKI C, Dagres N, Hindricks G
     Are 2 Left Atrial Appendage Guards Better Than 1? The Amulet IDE Randomized Trial.
     Circulation. 2022;145:739-741.
     

     >> Share

     
     
156. BOAS R, Sappler N, von Stulpnagel L, Klemm M, et al
     Periodic Repolarization Dynamics Identifies ICD Responders in Nonischemic Cardiomyopathy: A DANISH Substudy.
     Circulation. 2022;145:754-764.
     

     >> Share

     
     
157. GALEA R, De Marco F, Meneveau N, Aminian A, et al
     Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
     Circulation. 2022;145:724-738.
     

     >> Share

     
     
158. LUBITZ SA, Atlas SJ, Ashburner JM, Trisini Lipsanopoulos AT, et al
     Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: the VITAL-AF Randomized Controlled Trial.
     Circulation. 2022 Mar 2. doi: 10.1161/CIRCULATIONAHA.121.057014.
     

     >> Share

     
     
159. YOSHIDA T, Nakamura A, Funada J, Amino M, et al
     Efficacy and Safety of Edoxaban 15 mg According to Renal Function in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the ELDERCARE-AF Trial.
     Circulation. 2022;145:718-720.
     

     >> Share

     
     February 2022
160. 
     Correction to: Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
     Circulation. 2022;145:e640.
     

     >> Share

     
     
161. VAN OUWERKERK AF, Bosada FM, van Duijvenboden K, Houweling AC, et al
     Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
     Circulation. 2022;145:606-619.
     

     >> Share

     
     
162. HAUSLER KG, Eichner FA, Heuschmann PU, Fiebach JB, et al
     MRI-Detected Brain Lesions and Cognitive Function in Atrial Fibrillation Patients Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial.
     Circulation. 2022 Feb 9. doi: 10.1161/CIRCULATIONAHA.121.056320.
     

     >> Share

     
     
163. RIVARD L, Friberg L, Conen D, Healey JS, et al
     Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration.
     Circulation. 2022;145:392-409.
     

     >> Share

     
     
164. PELTENBURG PJ, Kallas D, Bos JM, Lieve KVV, et al
     An International Multicenter Cohort Study on beta-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
     Circulation. 2022;145:333-344.
     

     >> Share

     
     
165. KNOPS RE, van der Stuijt W, Delnoy PPHM, Boersma LVA, et al
     Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
     Circulation. 2022;145:321-329.
     

     >> Share

     
     January 2022
166. GOTO S, Goto S
     A Patient-Level Meta-Analysis: The End of the Era of Direct Oral Anticoagulant Developmental Trials in Patients With Atrial Fibrillation?
     Circulation. 2022;145:256-258.
     

     >> Share

     
     
167. WADA Y, Yang T, Shaffer CM, Daniel LL, et al
     Common Ancestry-Specific Ion Channel Variants Predispose to Drug-Induced Arrhythmias.
     Circulation. 2022;145:299-308.
     

     >> Share

     
     
168. CARNICELLI AP, Hong H, Connolly SJ, Eikelboom J, et al
     Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex.
     Circulation. 2022 Jan 5. doi: 10.1161/CIRCULATIONAHA.121.056355.
     

     >> Share

     
     December 2021
169. BAHNSON TD, Giczewska A, Mark DB, Russo AM, et al
     Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results from the CABANA Trial.
     Circulation. 2021 Dec 22. doi: 10.1161/CIRCULATIONAHA.121.055297.
     

     >> Share

     
     
170. SAMUEL M, Nattel S
     Fish Oil Supplements May Increase the Risk for Atrial Fibrillation: What Does This Mean?
     Circulation. 2021;144:1991-1994.
     

     >> Share

     
     
171. MIRANDA-ARBOLEDA AF, Mohammad S, Baranchuk A
     Wide Complex Tachycardia and Syncope in the Emergency Department.
     Circulation. 2021;144:2040-2042.
     

     >> Share

     
     
172. STEINBERG C, Dognin N, Sodhi A, Champagne C, et al
     Driving Restrictions and Early Arrhythmias in Patients Receiving a Secondary Prevention Implantable Cardioverter-Defibrillator (DREAM-ICD-II study).
     Circulation. 2021 Dec 16. doi: 10.1161/CIRCULATIONAHA.121.056471.
     

     >> Share

     
     
173. WARD-CAVINESS CK
     Accelerated Epigenetic Aging and Incident Atrial Fibrillation: New Outlook on an Immutable Risk Factor?
     Circulation. 2021;144:1912-1914.
     

     >> Share

     
     November 2021
174. HANKEY GJ
     Embolic Stroke of Undetermined Source: Can We Identify Subgroups With High Risk for Atrial Fibrillation Who May Benefit From Oral Anticoagulation?
     Circulation. 2021;144:1747-1749.
     

     >> Share

     
     
175. FINOCCHIARO G, Westaby J, Bhatia R, Malhotra A, et al
     Sudden Death in Female Athletes: Insights From a Large Regional Registry in the United Kingdom.
     Circulation. 2021;144:1827-1829.
     

     >> Share

     
     
176. SASMITA BR, Luo S, Huang B
     Wide and Narrow QRS Complex Tachycardia With Cycle Length Alternans: What Is the Mechanism?
     Circulation. 2021;144:1824-1826.
     

     >> Share

     
     
177. AGUILAR M, Macle L, Deyell MW, Yao R, et al
     The Influence of Monitoring Strategy on Assessment of Ablation Success and Post-ablation Atrial Fibrillation Burden Assessment: Implications for Practice and Clinical Trial Design.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056109.
     

     >> Share

     
     
178. SCHMIDT AS, Lauridsen KG, Moller DS, Christensen PD, et al
     Anterior-Lateral Versus Anterior-Posterior Electrode Position for Cardioverting Atrial Fibrillation.
     Circulation. 2021 Nov 24. doi: 10.1161/CIRCULATIONAHA.121.056301.
     

     >> Share

     
     
179. BERTERO E, Nickel A, Kohlhaas M, Hohl M, et al
     Loss of Mitochondrial Ca(2+) Uniporter Limits Inotropic Reserve and Provides Trigger and Substrate for Arrhythmias in Barth Syndrome Cardiomyopathy.
     Circulation. 2021;144:1694-1713.
     

     >> Share

     
     
180. KIRCHHOF P
     In Patients With Recently Diagnosed Atrial Fibrillation, Think Anticoagulation and Rhythm Control.
     Circulation. 2021;144:1587-1589.
     

     >> Share

     
     
181. KHURSHID S, Friedman S, Reeder C, Di Achille P, et al
     Electrocardiogram-based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation.
     Circulation. 2021 Nov 8. doi: 10.1161/CIRCULATIONAHA.121.057480.
     

     >> Share

     
     
182. ROMANI F, Monasky MM, Pappone C
     Letter by Romani et al Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
     Circulation. 2021;144:e280-e281.
     

     >> Share

     
     
183. LEOR J, Ram E, Naftali-Shani N, Shaihov-Teper O, et al
     Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
     Circulation. 2021;144:e282.
     

     >> Share

     
     October 2021
184. YAZAKI Y, Nakamura M, Iijima R, Yasuda S, et al
     Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
     Circulation. 2021;144:1449-1451.
     

     >> Share

     
     
185. BELHASSEN B, Shauer A, Biton Y
     Left Bundle-Branch Block Tachycardia After Transcatheter Aortic Valve Replacement.
     Circulation. 2021;144:1444-1448.
     

     >> Share

     
     
186. BAHIT MC, Sacco RL, Easton JD, Meyerhoff J, et al
     Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial.
     Circulation. 2021 Oct 15. doi: 10.1161/CIRCULATIONAHA.121.055176.
     

     >> Share

     
     
187. HIGUCHI S, Goldschlager N, Gerstenfeld EP
     Atrioventricular Block With Narrow and Wide QRS: The Pause That Refreshes.
     Circulation. 2021;144:1262-1264.
     

     >> Share

     
     
188. GENCER B, Djousse L, Al-Ramady OT, Cook NR, et al
     Effect of Long-Term Marine Omega-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.
     Circulation. 2021 Oct 6. doi: 10.1161/CIRCULATIONAHA.121.055654.
     

     >> Share

     
     September 2021
189. ROBERTS JD, Vittinghoff E, Lu AT, Alonso A, et al
     Epigenetic Age and the Risk of Incident Atrial Fibrillation.
     Circulation. 2021 Sep 30. doi: 10.1161/CIRCULATIONAHA.121.056456.
     

     >> Share

     
     
190. HULSURKAR MM, Lahiri SK, Moore O, Moreira LM, et al
     Atrial-Specific LKB1 Knockdown Represents a Novel Mouse Model of Atrial Cardiomyopathy With Spontaneous Atrial Fibrillation.
     Circulation. 2021;144:909-912.
     

     >> Share

     
     
191. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
     Polymorphic Ventricular Tachycardia: Terminology, Mechanism, Diagnosis, and Emergency Therapy.
     Circulation. 2021;144:823-839.
     

     >> Share

     
     
192. SUN Z, Wang L, Han L, Wang Y, et al
     Functional Calsequestrin-1 Is Expressed in the Heart and Its Deficiency Is Causally Related to Malignant Hyperthermia-Like Arrhythmia.
     Circulation. 2021;144:788-804.
     

     >> Share

     
     August 2021
193. MACHEREY S, Sinning JM, Mauri V
     Wide QRS Complex Bradycardia in a Hemodynamically Unstable Young Woman.
     Circulation. 2021;144:659-661.
     

     >> Share

     
     
194. AN ZY, Peng D, Shi YJ
     A Patient With Acute Shortness of Breath and Inferior ST-Segment Elevation: A Diagnostic Trap.
     Circulation. 2021;144:577-579.
     

     >> Share

     
     
195. RAAD N, Bittihn P, Cacheux M, Jeong D, et al
     Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
     Circulation. 2021;144:441-454.
     

     >> Share

     
     
196. CHEANG S, LeLorier P, Gajewski K
     Diffuse ST-Segment Elevation With Idiopathic Malignant Ventricular Arrhythmia.
     Circulation. 2021;144:399-402.
     

     >> Share

     
     July 2021
197. RILLIG A, Magnussen C, Ozga AK, Suling A, et al
     Early Rhythm Control Therapy in Patients with Atrial Fibrillation and Heart Failure.
     Circulation. 2021 Jul 30. doi: 10.1161/CIRCULATIONAHA.121.056323.
     

     >> Share

     
     
198. REAL C, Morales T, Viana-Tejedor A
     An Unusual Call From the Urology Ward.
     Circulation. 2021;144:324-327.
     

     >> Share

     
     
199. FRADLEY MG, Beckie TM, Brown SA, Cheng RK, et al
     Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A Scientific Statement From the American Heart Association.
     Circulation. 2021;144:e41-e55.
     

     >> Share

     
     
200. FELKER GM, Butler J, Ibrahim NE, Pina IL, et al
     Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
     Circulation. 2021;144:180-182.
     

     >> Share

     
     
201. VISKIN S, Marai I, Rosso R
     Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
     Circulation. 2021;144:85-89.
     

     >> Share

     
     June 2021
202. PASSMAN R
     "Pill-in-Pocket" Anticoagulation for Atrial Fibrillation: Fiction, Fact, or Foolish?
     Circulation. 2021;143:2211-2213.
     

     >> Share

     
     
203. BHASIN D, Kumar R, Gupta A
     A Young Woman With Palpitations: A Poison or a Remedy?
     Circulation. 2021;143:2312-2315.
     

     >> Share

     
     
204. BOULET J, Massie E, Liszkowski M
     A Silent Arrhythmia: How Would You Manage This Patient?
     Circulation. 2021;143:2205-2207.
     

     >> Share

     
     May 2021
205. SINGH M, Joglar J
     Morbidly Obese Patients With Symptomatic Atrial Fibrillation: Why Are We Holding Back on Bariatric Surgery?
     Circulation. 2021;143:1838-1840.
     

     >> Share

     
     
206. WALDMANN V, Combes N, Narayanan K, Marijon E, et al
     Response by Waldmann et al to Letter Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
     Circulation. 2021;143:e900-e901.
     

     >> Share

     
     
207. FERRERO P, Chessa M
     Letter by Ferrero and Chessa Regarding Article, "Long-Term Follow-Up of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator: The DAI-T4F Nationwide Registry".
     Circulation. 2021;143:e898-e899.
     

     >> Share

     
     April 2021
208. GILLIS AM, Wilton SB
     Rhythm Control of Atrial Fibrillation: The Earlier the Better?
     Circulation. 2021;143:1639-1641.
     

     >> Share

     
     
209. KANEKO H, Yano Y, Itoh H, Morita K, et al
     Association of Blood Pressure Classification Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation.
     Circulation. 2021 Apr 22. doi: 10.1161/CIRCULATIONAHA.120.052624.
     

     >> Share

     
     
210. RANSOM JL, Wong KC
     Palpitations in the Clinic.
     Circulation. 2021;143:1631-1634.
     

     >> Share

     
     
211. BENZ AP, Hijazi Z, Lindback J, Connolly SJ, et al
     Biomarker-Based Risk Prediction With The ABC-AF Scores in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation.
     Circulation. 2021 Apr 14. doi: 10.1161/CIRCULATIONAHA.120.053100.
     

     >> Share

     
     
212. DAI XC, An ZY
     Severe Arrhythmia Caused by a Chinese Herb Liquor: What Is the Diagnosis?
     Circulation. 2021;143:1450-1451.
     

     >> Share

     
     March 2021
213. GIUDICESSI JR, Schram M, Bos JM, Galloway CD, et al
     Artificial Intelligence-Enabled Assessment of the Heart Rate Corrected QT Interval Using a Mobile Electrocardiogram Device.
     Circulation. 2021;143:1274-1286.
     

     >> Share

     
     
214. ROSENBERG MA
     Trusting Magic: Interpretability of Predictions From Machine Learning Algorithms.
     Circulation. 2021;143:1299-1301.
     

     >> Share

     
     
215. PENG D, Liu X, Pan Y
     Irregular Complex Tachycardia: Not Dual Atrioventricular Nodal Nonreentrant Tachycardia.
     Circulation. 2021;143:1173-1176.
     

     >> Share

     
     
216. CONSTANT DIT BEAUFILS AL, Huttin O, Jobbe-Duval A, Senage T, et al
     Replacement Myocardial Fibrosis in Patients with Mitral Valve Prolapse: Relation to Mitral Regurgitation, Ventricular Remodeling and Arrhythmia.
     Circulation. 2021 Mar 12. doi: 10.1161/CIRCULATIONAHA.120.050214.
     

     >> Share

     
     
217. PILLAI A, Ellenbogen KA, Padala SK
     A Tale of 2 Blocks.
     Circulation. 2021;143:1062-1065.
     

     >> Share

     
     February 2021
218. ARAS D, Ozeke O, Topaloglu S
     When You Hear Hoofbeats, Look for Horses, Not Zebras.
     Circulation. 2021;143:862-864.
     

     >> Share

     
     
219. WORKMAN V, Forrest JK, Enriquez A
     A Case of Presyncope After Transcatheter Aortic Valve Replacement.
     Circulation. 2021;143:857-861.
     

     >> Share

     
     
220. YAMAGUCHI N, Xiao J, Narke D, Shaheen D, et al
     Cardiac Pressure Overload Decreases ETV1 Expression in the Left Atrium, Contributing to Atrial Electrical and Structural Remodeling.
     Circulation. 2021;143:805-820.
     

     >> Share

     
     
221. KARABINOS I, Kostaki P, Panagopoulos Z
     Bizarre Downsloping ST Segment Elevation Challenge.
     Circulation. 2021;143:599-601.
     

     >> Share

     
     
222. CHEN AY, Nishimura T, Tung R
     Narrowing the Differential Diagnosis for a Wide Complex Tachycardia.
     Circulation. 2021;143:503-506.
     

     >> Share

     
     January 2021
223. TOMCSANYI J, Paulik R, Fresz T
     Acute Coronary Syndrome With Tall R Waves and Inverted T Waves in the Precordial Leads: An Ignored Entity.
     Circulation. 2021;143:397-400.
     

     >> Share

     
     
224. KANAGASUNDRAM AN, Richardson TD, Stevenson WG
     The Heart Rate of Ventricular Tachycardia.
     Circulation. 2021;143:227-229.
     

     >> Share

     
     
225. NISHIMURA T, Upadhyay GA, Aziz ZA, Beaser AD, et al
     Circuit Determinants of Ventricular Tachycardia Cycle Length: Characterization of Fast and Unstable Human Ventricular Tachycardia.
     Circulation. 2021;143:212-226.
     

     >> Share

     
     
226. GOLD MR, Lambiase PD, El-Chami MF, Knops RE, et al
     Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
     Circulation. 2021;143:7-17.
     

     >> Share

     
     December 2020
227. PAL N, Padala S, Klein K
     Letter by Pal et al Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e501-e502.
     

     >> Share

     
     
228. BELLEY-COTE EP, Whitlock RP
     Letter by Belley-Cote and Whitlock Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e503.
     

     >> Share

     
     
229. MAHMOOD E, Sharkey A, Matyal R, Mahmood F, et al
     Response by Mahmood et al to Letter Regarding Article, "Impact of Left Atrial Appendage Exclusion on Short-Term Outcomes in Isolated Coronary Artery Bypass Graft Surgery".
     Circulation. 2020;142:e504-e505.
     

     >> Share

     
     October 2020
230. MACONOCHIE IK, Aickin R, Hazinski MF, Atkins DL, et al
     Pediatric Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     

     >> Share

     
     
231. BERG KM, Soar J, Andersen LW, Bottiger BW, et al
     Adult Advanced Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
     Circulation. 2020;142.
     

     >> Share

     
     June 2020
232. MAHMOOD E, Matyal R, Mahmood F, Xu X, et al
     Impact of Left Atrial Appendage Exclusion on Short Term Outcomes In Isolated Coronary Artery Bypass Graft Surgery.
     Circulation. 2020 Jun 3. doi: 10.1161/CIRCULATIONAHA.119.044642.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share